• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

没食子酸通过增加低密度脂蛋白受体积累促进 HepG2 细胞摄取低密度脂蛋白。

Gallic Acid Can Promote Low-Density Lipoprotein Uptake in HepG2 Cells via Increasing Low-Density Lipoprotein Receptor Accumulation.

机构信息

College of Science, Yunnan Agricultural University, Kunming 650201, China.

Key Laboratory of Pu-er Tea Science, Ministry of Education, Yunnan Agricultural University, Kunming 650201, China.

出版信息

Molecules. 2024 Apr 26;29(9):1999. doi: 10.3390/molecules29091999.

DOI:10.3390/molecules29091999
PMID:38731489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11085419/
Abstract

Gallic acid (GA) is a type of polyphenolic compound that can be found in a range of fruits, vegetables, and tea. Although it has been confirmed it improves non-alcoholic fatty liver disease (NAFLD), it is still unknown whether GA can improve the occurrence of NAFLD by increasing the low-density lipoprotein receptor (LDLR) accumulation and alleviating cholesterol metabolism disorders. Therefore, the present study explored the effect of GA on LDLR and its mechanism of action. The findings indicated that the increase in LDLR accumulation in HepG2 cells induced by GA was associated with the stimulation of the epidermal growth factor receptor-extracellular regulated protein kinase (EGFR-ERK1/2) signaling pathway. When the pathway was inhibited by EGFR mab cetuximab, it was observed that the activation of the EGFR-ERK1/2 signaling pathway induced by GA was also blocked. At the same time, the accumulation of LDLR protein and the uptake of LDL were also suppressed. Additionally, GA can also promote the accumulation of forkhead box O3 (FOXO3) and suppress the accumulation of hepatocyte nuclear factor-1α (HNF1α), leading to the inhibition of proprotein convertase subtilisin/kexin 9 (PCSK9) mRNA expression and protein accumulation. This ultimately results in increased LDLR protein accumulation and enhanced uptake of LDL in cells. In summary, the present study revealed the potential mechanism of GA's role in ameliorating NAFLD, with a view of providing a theoretical basis for the dietary supplementation of GA.

摘要

没食子酸(GA)是一种多酚化合物,存在于多种水果、蔬菜和茶中。虽然已经证实它可以改善非酒精性脂肪性肝病(NAFLD),但尚不清楚 GA 是否可以通过增加低密度脂蛋白受体(LDLR)积累和缓解胆固醇代谢紊乱来改善 NAFLD 的发生。因此,本研究探讨了 GA 对 LDLR 的影响及其作用机制。研究结果表明,GA 诱导 HepG2 细胞中 LDLR 积累的增加与表皮生长因子受体-细胞外调节蛋白激酶(EGFR-ERK1/2)信号通路的刺激有关。当该途径被 EGFR mab cetuximab 抑制时,观察到 GA 诱导的 EGFR-ERK1/2 信号通路的激活也被阻断。同时,LDLR 蛋白的积累和 LDL 的摄取也受到抑制。此外,GA 还可以促进叉头框 O3(FOXO3)的积累,抑制肝细胞核因子-1α(HNF1α)的积累,从而抑制前蛋白转化酶枯草杆菌蛋白酶/kexin9(PCSK9)mRNA 表达和蛋白积累。这最终导致 LDLR 蛋白积累增加和细胞内 LDL 的摄取增强。综上所述,本研究揭示了 GA 改善 NAFLD 的潜在作用机制,为 GA 的饮食补充提供了理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5dd/11085419/a989c2db93ad/molecules-29-01999-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5dd/11085419/267819e5141a/molecules-29-01999-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5dd/11085419/85a8fa48da1a/molecules-29-01999-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5dd/11085419/10b82effd24b/molecules-29-01999-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5dd/11085419/5c10bc48efed/molecules-29-01999-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5dd/11085419/a989c2db93ad/molecules-29-01999-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5dd/11085419/267819e5141a/molecules-29-01999-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5dd/11085419/85a8fa48da1a/molecules-29-01999-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5dd/11085419/10b82effd24b/molecules-29-01999-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5dd/11085419/5c10bc48efed/molecules-29-01999-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5dd/11085419/a989c2db93ad/molecules-29-01999-g005.jpg

相似文献

1
Gallic Acid Can Promote Low-Density Lipoprotein Uptake in HepG2 Cells via Increasing Low-Density Lipoprotein Receptor Accumulation.没食子酸通过增加低密度脂蛋白受体积累促进 HepG2 细胞摄取低密度脂蛋白。
Molecules. 2024 Apr 26;29(9):1999. doi: 10.3390/molecules29091999.
2
Enhanced pro-protein convertase subtilisin/kexin type 9 expression by C-reactive protein through p38MAPK-HNF1α pathway in HepG2 cells.C反应蛋白通过p38丝裂原活化蛋白激酶-HNF1α途径增强HepG2细胞中前蛋白转化酶枯草杆菌蛋白酶/kexin 9型的表达。
J Cell Mol Med. 2016 Dec;20(12):2374-2383. doi: 10.1111/jcmm.12931. Epub 2016 Sep 15.
3
Ascorbic acid enhances low-density lipoprotein receptor expression by suppressing proprotein convertase subtilisin/kexin 9 expression.抗坏血酸通过抑制前蛋白转化酶枯草溶菌素/柯萨奇蛋白酶 9 的表达来增强低密度脂蛋白受体的表达。
J Biol Chem. 2020 Nov 20;295(47):15870-15882. doi: 10.1074/jbc.RA120.015623. Epub 2020 Sep 10.
4
An Unbiased Mass Spectrometry Approach Identifies Glypican-3 as an Interactor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) in Hepatocellular Carcinoma Cells.一种无偏倚的质谱方法鉴定出磷脂酰肌醇蛋白聚糖-3作为肝细胞癌细胞中前蛋白转化酶枯草杆菌蛋白酶/kexin 9型(PCSK9)和低密度脂蛋白受体(LDLR)的相互作用分子。
J Biol Chem. 2016 Nov 18;291(47):24676-24687. doi: 10.1074/jbc.M116.746883. Epub 2016 Oct 7.
5
Alginate oligosaccharide enhances LDL uptake via regulation of LDLR and PCSK9 expression.海藻酸寡糖通过调节低密度脂蛋白受体(LDLR)和前蛋白转化酶枯草溶菌素9(PCSK9)的表达增强低密度脂蛋白(LDL)摄取。
J Nutr Biochem. 2015 Nov;26(11):1393-400. doi: 10.1016/j.jnutbio.2015.07.009. Epub 2015 Jul 30.
6
MG132, a proteasome inhibitor, enhances LDL uptake in HepG2 cells in vitro by regulating LDLR and PCSK9 expression.蛋白酶体抑制剂MG132通过调节低密度脂蛋白受体(LDLR)和前蛋白转化酶枯草溶菌素9(PCSK9)的表达,增强体外培养的HepG2细胞对低密度脂蛋白(LDL)的摄取。
Acta Pharmacol Sin. 2014 Aug;35(8):994-1004. doi: 10.1038/aps.2014.52. Epub 2014 Jul 21.
7
Epigallocatechin gallate induces an up-regulation of LDL receptor accompanied by a reduction of PCSK9 via the annexin A2-independent pathway in HepG2 cells.没食子儿茶素没食子酸酯通过 annexin A2 非依赖性途径诱导 HepG2 细胞中 LDL 受体上调和 PCSK9 减少。
Mol Nutr Food Res. 2017 Aug;61(8). doi: 10.1002/mnfr.201600836. Epub 2017 Mar 27.
8
Identification of neolignans with PCSK9 downregulatory and LDLR upregulatory activities from Penthorum chinense and the potential in cholesterol uptake by transcriptional regulation of LDLR via SREBP2.从过路黄中鉴定具有 PCSK9 下调和 LDLR 上调活性的新木脂素及其通过 SREBP2 对 LDLR 的转录调控在胆固醇摄取中的潜力。
J Ethnopharmacol. 2021 Oct 5;278:114265. doi: 10.1016/j.jep.2021.114265. Epub 2021 Jun 8.
9
Peroxisome Proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression.配体和去磷酸化诱导过氧化物酶体增殖物激活受体 γ 的激活,从而诱导蛋白水解酶枯草溶菌素 kexin 9 型和低密度脂蛋白受体的表达。
J Biol Chem. 2012 Jul 6;287(28):23667-77. doi: 10.1074/jbc.M112.350181. Epub 2012 May 16.
10
Beneficial impact of epigallocatechingallate on LDL-C through PCSK9/LDLR pathway by blocking HNF1α and activating FoxO3a.表没食子儿茶素没食子酸酯通过阻断肝细胞核因子1α(HNF1α)并激活叉头框蛋白O3a(FoxO3a),经前蛋白转化酶枯草溶菌素9(PCSK9)/低密度脂蛋白受体(LDLR)途径对低密度脂蛋白胆固醇(LDL-C)产生有益影响。
J Transl Med. 2020 May 12;18(1):195. doi: 10.1186/s12967-020-02362-4.

引用本文的文献

1
Regulatory mechanisms of hepatocyte PCSK9 expression: translating mechanistic insights into potential nutraceuticals.肝细胞中前蛋白转化酶枯草溶菌素9(PCSK9)表达的调控机制:将机制性见解转化为潜在的营养保健品
Chin Med. 2025 Aug 5;20(1):121. doi: 10.1186/s13020-025-01178-y.
2
Regulatory Mechanisms of Phenolic Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review.代谢功能障碍相关脂肪性肝病中酚酸的调节机制:综述
Antioxidants (Basel). 2025 Jun 20;14(7):760. doi: 10.3390/antiox14070760.
3
Integrating Strategy of Network Pharmacology, Molecular Dynamics Simulation, and Experimental Verification to Investigate the Potential Mechanism of Against Alcoholic Liver Injury.

本文引用的文献

1
Caffeine can alleviate non-alcoholic fatty liver disease by augmenting LDLR expression targeting EGFR.咖啡因可通过增强靶向表皮生长因子受体(EGFR)的低密度脂蛋白受体(LDLR)表达来缓解非酒精性脂肪性肝病。
Food Funct. 2023 Apr 3;14(7):3269-3278. doi: 10.1039/d2fo02701a.
2
Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss.非酒精性脂肪性肝病(NAFLD):病理生理学、临床管理和减肥效果的综述。
BMC Endocr Disord. 2022 Mar 14;22(1):63. doi: 10.1186/s12902-022-00980-1.
3
Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery.
整合网络药理学、分子动力学模拟和实验验证策略以探究[具体药物或物质]抗酒精性肝损伤的潜在机制
Foods. 2025 Jun 6;14(12):2008. doi: 10.3390/foods14122008.
4
Chlorogenic acid targets SIRT6 to relieve UVB - induced UV damage.绿原酸靶向沉默调节蛋白6以减轻紫外线B诱导的紫外线损伤。
Arch Dermatol Res. 2025 Mar 19;317(1):600. doi: 10.1007/s00403-025-04134-w.
5
Gallic acid: a dietary metabolite's therapeutic potential in the management of atherosclerotic cardiovascular disease.没食子酸:一种膳食代谢产物在动脉粥样硬化性心血管疾病管理中的治疗潜力。
Front Pharmacol. 2025 Jan 7;15:1515172. doi: 10.3389/fphar.2024.1515172. eCollection 2024.
6
Metabolic-Associated Fatty Liver Disease: The Influence of Oxidative Stress, Inflammation, Mitochondrial Dysfunctions, and the Role of Polyphenols.代谢相关脂肪性肝病:氧化应激、炎症、线粒体功能障碍的影响及多酚的作用
Pharmaceuticals (Basel). 2024 Oct 10;17(10):1354. doi: 10.3390/ph17101354.
7
Based on Network Pharmacology and Molecular Docking, the Active Components, Targets, and Mechanisms of in Improving Inflammation Were Excavated.基于网络药理学和分子对接技术,挖掘了 改善炎症的活性成分、作用靶点及作用机制。
Nutrients. 2024 Jun 13;16(12):1850. doi: 10.3390/nu16121850.
没食子酸在癌症治疗中的应用:分子机制与纳米递药系统增强疗效。
Food Chem Toxicol. 2021 Nov;157:112576. doi: 10.1016/j.fct.2021.112576. Epub 2021 Sep 25.
4
The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis.肠道微生物群在动脉粥样硬化中的胆固醇代谢作用。
Int J Mol Sci. 2021 Jul 28;22(15):8074. doi: 10.3390/ijms22158074.
5
Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis.肝脏胆固醇转运及其在非酒精性脂肪性肝病和动脉粥样硬化中的作用。
Prog Lipid Res. 2021 Jul;83:101109. doi: 10.1016/j.plipres.2021.101109. Epub 2021 Jun 11.
6
Gallic acid treats dust-induced NAFLD in rats by improving the liver's anti-oxidant capacity and inhibiting ROS/NFκβ/TNFα inflammatory pathway.没食子酸通过提高肝脏抗氧化能力和抑制ROS/NFκβ/TNFα炎症途径来治疗大鼠粉尘诱导的非酒精性脂肪性肝病。
Iran J Basic Med Sci. 2021 Feb;24(2):240-247. doi: 10.22038/IJBMS.2021.51036.11603.
7
Feedback regulation of coronary artery disease susceptibility gene ADTRP and LDL receptors LDLR/CD36/LOX-1 in endothelia cell functions involved in atherosclerosis.反馈调节参与动脉粥样硬化内皮细胞功能的冠心病易患基因 ADTRP 和 LDL 受体 LDLR/CD36/LOX-1。
Biochim Biophys Acta Mol Basis Dis. 2021 Jul 1;1867(7):166130. doi: 10.1016/j.bbadis.2021.166130. Epub 2021 Mar 18.
8
Gallic Acid Ameliorated Impaired Lipid Homeostasis in a Mouse Model of High-Fat Diet-and Streptozotocin-Induced NAFLD and Diabetes through Improvement of -oxidation and Ketogenesis.没食子酸通过改善β-氧化和生酮作用,减轻了高脂饮食和链脲佐菌素诱导的非酒精性脂肪性肝病和糖尿病小鼠模型中受损的脂质稳态。
Front Pharmacol. 2021 Feb 12;11:606759. doi: 10.3389/fphar.2020.606759. eCollection 2020.
9
Cholesterol synthesis disruption combined with a molecule-targeted drug is a promising metabolic therapy for EGFR mutant non-small cell lung cancer.胆固醇合成阻断与分子靶向药物联合使用是一种有前景的针对表皮生长因子受体(EGFR)突变的非小细胞肺癌的代谢疗法。
Transl Lung Cancer Res. 2021 Jan;10(1):128-142. doi: 10.21037/tlcr-20-812.
10
A structure of human Scap bound to Insig-2 suggests how their interaction is regulated by sterols.人源 Scap 与 Insig-2 结合的结构提示固醇如何调节它们的相互作用。
Science. 2021 Mar 5;371(6533). doi: 10.1126/science.abb2224. Epub 2021 Jan 14.